No Data
Zomedica (ZOM.US) will release its financial report after the market closes on November 7th.
Zomedica (ZOM.US) will release its financial report after the market closes on November 7th. How was its previous performance? In 2024 Q2, Zomedica reported a revenue of $6.131 million, a net income of -$-23.931 million, and an EPS of -$0.024. In 2023 Q3, the revenue was $6.347 million, net income was -$-0.491 million, and EPS was -$0.001. The above data is prepared under the US GAAP accounting standards. Please note: 1. For Hong Kong and US listed companies,
Zomedica Releases The Ear Cytology Quick Scan Protocol, A New Feature Available On The TRUVIEW Microscope Equipped With The TRUprep Automated Slide Preparation System
Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 P.m. ET
Zomedica Corp (ZOM) Q2 2024 Earnings Call Highlights: Diagnostics Surge Amid Revenue Challenges
Zomedica Expands Distribution Agreement in Europe With Grovet
Zomedica Completes Renovation of Production Site in Minnesota
No Data
No Data